Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes

Drugs
W W Fleischhacker, M Hummer

Abstract

The current state of the art of the pharmacological treatment of schizophrenia, and a review of the latest findings in antipsychotic drug development are presented. A first step in optimising treatment is an increase in the awareness and implementation of existing treatment standards. The introduction of clozapine challenges the view that all antipsychotics are of similar efficacy; the drug has an established superiority over some of the traditional antipsychotics in treatment-resistant patients. Newer agents such as zotepine, risperidone, quetiapine, olanzapine and sertindole, which have a lower risk of producing extrapyramidal motor symptoms, have been developed in the wake of clozapine. While it is still common to switch nonresponding patients to an antipsychotic of a different chemical class, clozapine treatment remains the only strategy based on sound scientific evidence in these patients, although the novel antipsychotics give rise to hope. Alternatively, combination treatment with benzodiazepines, lithium or an anticonvulsant has been employed. If treatment with a depot antipsychotic is planned, it is advisable to start a patient on the oral form of the same drug in order to obtain dose requirements and tolerability info...Continue Reading

Citations

Dec 9, 2000·Perspectives in Psychiatric Care·N L KeltnerJ E Johnson
Mar 14, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·M C MauriP Papa
Oct 31, 2002·Human Psychopharmacology·Matteo BalestrieriCesario Bellantuono
Nov 28, 2002·Journal of Clinical Psychopharmacology·Matthias J MüllerUNKNOWN Amisulpride Study Group
Feb 7, 2007·Current Opinion in Psychiatry·Gary Remington
Jun 4, 2002·The British Journal of Psychiatry : the Journal of Mental Science·R Hamish McAllister-Williams, I Nicol Ferrier
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Gary Remington
Mar 30, 1999·Nature Biotechnology·A Persidis, R M Copen
Dec 6, 2000·Journal of Clinical Psychopharmacology·E WeissW W Fleischhacker
Oct 20, 1998·Journal of the American Geriatrics Society·S Gaile, J A Noviasky
May 22, 2010·Expert Opinion on Drug Safety·Michael RiedelRebecca Schennach-Wolff
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C H Miller, W W Fleischhacker
Oct 6, 1998·European Journal of Pharmacology·A Newman-TancrediM J Millan
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Vladimir LernerRael D Strous

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.